Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Sherman

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 6, 2010
Dual catheter technique for the treatment of severe coronary artery perforationsYanai Ben-Gal, Giora Weisz, Michael B Collins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogsKun-Lun He, Geng-Hua Yi, Warren Sherman, et al.
American Heart Journal|October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarctionThomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
JACC. Cardiovascular Interventions|February 24, 2018
First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell DeliveryWarren Sherman, Jozef Bartunek, Dariouch Dolatabadi, et al.
Journal of the American College of Cardiology|December 12, 2002
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarctionSimon R Dixon, Robert J Whitbourn, Michael W Dae, et al.
Journal of the American College of Cardiology|December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionJoshua M Hare, Jay H Traverse, Timothy D Henry, et al.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
American Heart Journal|May 28, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyThomas J Povsic, Candice Junge, Adel Nada, et al.
Cell Transplantation|October 31, 2012
Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine modelYanping Cheng, Genghua Yi, Gerard B Conditt, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 6, 2010
Dual catheter technique for the treatment of severe coronary artery perforationsYanai Ben-Gal, Giora Weisz, Michael B Collins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 22, 2005
Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogsKun-Lun He, Geng-Hua Yi, Warren Sherman, et al.
American Heart Journal|October 11, 2011
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarctionThomas J Povsic, Christopher M O'Connor, Timothy Henry, et al.
JACC. Cardiovascular Interventions|February 24, 2018
First-in-Human Use of a Retention-Enhanced Catheter for Endomyocardial Cell DeliveryWarren Sherman, Jozef Bartunek, Dariouch Dolatabadi, et al.
Journal of the American College of Cardiology|December 12, 2002
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarctionSimon R Dixon, Robert J Whitbourn, Michael W Dae, et al.
Journal of the American College of Cardiology|December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionJoshua M Hare, Jay H Traverse, Timothy D Henry, et al.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
American Heart Journal|May 28, 2013
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW studyThomas J Povsic, Candice Junge, Adel Nada, et al.
Cell Transplantation|October 31, 2012
Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine modelYanping Cheng, Genghua Yi, Gerard B Conditt, et al.
ESC Heart Failure|October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomesJozef Bartunek, Andre Terzic, Beth A Davison, et al.
Pageof 5